Trudeau expresses “tremendous confidence” in the AstraZeneca vaccine following Canada’s first shot-related death
Canadian Prime Minister Justin TrudeauJustin Pierre James TrudeauBiden, Harris, Harry and Meghan added, “Vax Live: The Concert to Reunite the World” Canadian health officials warn that the daily COVID-19 caseload could nearly double by the end of the month. Trudeau, his wife, will receive the first dose of the AstraZeneca vaccine on Friday MORE expressed “tremendous confidence” in AstraZeneca’s COVID-19 vaccine following the first reported death in Canada related to the shot.
On a Canadian radio broadcast, according to City News 1130, Trudeau expressed confidence that all COVID-19 vaccines used in Canada, including AstraZenecas, will be used.
“Every single vaccine used in Canada has been approved as safe by Health Canada, and I have great confidence in all vaccines, including AstraZeneca. I shot the AstraZeneca myself last week and didn’t even hesitate, ”said Trudeau “The Rick Howe Show.”
Trudeau getting his first shot of AstraZeneca’s vaccine last Fridayadded that the risk of blood clots from COVID-19 “is much greater than the very, very rare but real risk of side effects from AstraZeneca”.
The remarks come after Canada’s health department reported that a 54-year-old woman died in Quebec after a rare blood clot. Her death is believed to be the first in Canada to be linked to a COVID-19 vaccination.
The Canadian health authority said the woman had experienced thrombosis with thrombocytopenia with unusual blood clots with low platelets after being vaccinated with the AstraZeneca COVID-19 vaccine, according to Canadian news agency Global News.
According to Global News, health officials are “collecting additional information on the case,” and details “are being considered as part of ongoing monitoring of the risk of rare blood clots with low platelets following immunization with the AstraZeneca and COVISHIELD vaccines.”
Reuters reported that Ms. Francine Boyer received a shot on April 9 and died on April 23 in a health facility where she was being treated for fatigue and headaches.
The Hill has contacted the Canadian Health Department for comment.
Public confidence in AstraZeneca’s vaccine has decreased in recent months due to blood clotting incidents related to the vaccine in other countries.
A handful of European countries have temporarily stopped using the vaccine, despite reports of rare blood clotting, although some have resumed use.